Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Total 13F shares
- 29,599,358
- Total 13F value
- $10,998,630,513
- Share change
- +1,232,152
- Put/Call ratio
- 90%
- SEC-reported price per share
- $371.67
- Number of holders
- 419
- Value change
- +$477,119,199
- Number of buys
- 263
- Number of sells
- 144
- Shares outstanding
- 29,463,330
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
419
Top holders
10
KRYS full security history
Ownership snapshot
Full 13F holder table
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Krish S. Krishnan
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
13D/G row: Krish S. Krishnan
Showing 1-6 of 15 holder rows.
Quick read
Krish S. Krishnan leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Krish S. Krishnan's linked filing trail.
Comparable ownership
Top 5
Krish S. Krishnan
12%
VANGUARD PORTFOLIO MANAGEMENT LLC
5%
STATE STREET CORP
4.4%
Laurent Louis Jean Goux
0%
FMR LLC
15%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Krish S. Krishnan |
13D/G
|
12%
|
$906,060,757
3,388,283 shares
|
$0 | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
Vanguard Portfolio Management · Company
|
5%
|
$382,084,101
1,479,111 shares
|
$0 | 31 Mar 2026 |
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
4.4%
from 13D/G
|
$339,544,591
1,314,434 shares
|
— | 31 Mar 2026 |
| Laurent Louis Jean Goux |
3/4/5
EVP, Head of International
|
0%
|
$250,565
919 shares
|
— | 01 Mar 2026 |
| FMR LLC |
13F
Company
|
15%
|
$1,129,888,252
4,373,987 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
13%
|
$1,017,898,595
3,940,456 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
419
Shares
29,599,358
Rows available
419
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
368
Q2 2026 holders
419
Holder diff
51
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|